XJPX
2914
Market cap67bUSD
Jun 18, Last price
6,087.00JPY
1D
0.26%
1Q
4.10%
Jan 2017
58.35%
Name
Japan Tobacco Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Japan Tobacco Inc., established in Tokyo, Japan in 1898, is a global enterprise involved in the manufacturing and distribution of tobacco products, prescription medications, and processed food items for both Japanese and international consumers. Its business is structured across four key divisions: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. The company's extensive tobacco offerings encompass traditional options like cigarettes, cigars, pipe tobacco, oral tobacco, waterpipe tobacco, kretek, and fine cut products, marketed under prominent brands such as Winston, Camel, MEVIUS, and LD. Additionally, Japan Tobacco Inc. provides a range of reduced-risk alternatives, including tobacco-infused vapor and heated tobacco products, alongside e-vapor devices, under brand names like Ploom, Logic, Ploom TECH, and Ploom S. Its pharmaceutical operations are dedicated to the research, development, production, and sale of prescription drugs, addressing therapeutic needs in areas such as cardiovascular, renal and metabolic, immunology, and neurological health. Furthermore, the processed food division delivers a varied selection of goods, including staple items like frozen noodles, okonomiyaki, and pre-cooked rice, as well as ambient processed foods, bakery items, and various seasonings, including yeast extracts and oyster sauce.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||